PharmaSols Partnering with Molecular Templates, Inc.
30 September 2021
PharmaSols is delighted to be partnering with Molecular Templates, Inc. (MTEM) on their phase 1b study of MT-5111 in advanced human epidermal growth factor receptor 2 (HER2)-expressing solid tumours across multiple sites in Australia and New Zealand.
How To Avoid Costly Errors in Ethics and Regulatory Submissions
08 September 2021
Ethics and Regulatory applications are a necessary complexity that can determine trial start-up timeframes or, in some cases, throw trial startup timelines immediately off-target if done incorrectly.
Selecting who should be responsible for completing this application can also have a significant impact on the continuity of the trial.
